EQT To Buy Dutch Life Sciences Investment Firm LSP For EUR 450 Mln - Quick Facts

EQT AB (EQT) announced Wednesday that it has signed an agreement to acquire Life Sciences Partners or LSP, a European life sciences venture capital firm.

The upfront consideration amounts to 450 million euros on a cash- and debt free basis, comprising of 25 percent cash and 75 percent new EQT AB publicly traded shares, with a potential additional earn-out payment of 25 million euros.

The transaction is is expected to close in Q1 2022, subject to customary closing conditions, including antitrust, regulatory and certain fund investor clearances. The deal will be accretive to EQT AB's earnings in 2022.

EQT AB will acquire 100 percent of the LSP management company and 20 percent of the right to carried interest in select LSP funds. In addition, EQT AB will be entitled to 35 percent of the carried interest of future funds, which is in line with existing EQT policies.

Amsterdam, the Netherlands -based LSP has about 2.2 billion euros of assets under management and a team of 34 professionals. Over the past two decades, LSP has invested in over 150 life sciences companies. The entire LSP team, including all partners and employees, will join EQT.

LSP is expected to generate around 37 million euros in revenues and around 24 million euros in EBITDA during 2021. The proposed consideration is expected to equate to a mid-teens EBITDA multiple on a run-rate basis at completion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Creminelli Fine Meats is recalling around 4,207 pounds of ready-to-eat or RTE parmesan salami sticks citing misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves 2.6-oz. plastic pouches containing "CREMINELLI FINE MEATS salami minis UNCURED ITALIAN SALAMI PARMESAN" with "BES The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds.
Follow RTT